N-ACETYL CYSTEINE IN THE ADJUNCTIVE TREATMENT OF OBSESSIVE COMPUSLIVE DISORDER: A 16-week, Double-Blind, Randomised, Placebo-Controlled Study

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/GNT1104460

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

The aim of our proposed study, is investigate the efficacy and safety of adjunctive N-acetyl cysteine (NAC), an amino-acid based agent in the treatment of 200 adults with diagnosed OCD. The study proposed is a 16-week, doubled-blind, randomised, placebo-controlled trial. If NAC is found to be effective in this study, the treatment of OCD will be strongly influenced, resulting in global impact for the potential alleviation of suffering for those with the mental disorder.

Funded Activity Details

Start Date: 01-01-2016

End Date: 01-01-2019

Funding Scheme: Project Grants

Funding Amount: $850,448.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Complementary and Alternative Medicine not elsewhere classified

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

anxiety disorders | clinical trial | nutrition supplementation | obsessive-compulsive disorder (OCD) | psychiatric disorders

Related Links